BMJ· 2020Q1· Derleme
Gestasyonel diyabet öyküsü olan kadınlarda tip 2 diyabete ilerleme: sistematik derleme ve meta-analiz
Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis
- 1.121atıf
- Q1SCImago
- 2020yıl
Kısa özet
Gestasyonel diyabet mellitus (GDM) öyküsü olan kadınlarda, sağlıklı kontrollere kıyasla tip 2 diyabet mellitus (T2DM) geliştirme riski neredeyse 10 kat daha fazladır.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- Önceki GDM öyküsü olan kadınların T2DM geliştirme olasılığı kontrollere göre neredeyse 10 kat daha fazladır.
- GDM öyküsü olan kadınlarda T2DM insidansı için kümülatif göreceli risk 9.51 (95% GA 7.14 - 12.67) olarak tahmin edilmiştir.
- T2DM'nin kümülatif insidansı etnik kökene göre farklılık göstermiştir: %16.46 (karışık), %15.58 (beyaz olmayan) ve %9.91 (beyaz).
- Çalışma yaşı, vücut kitle indeksi, yayın yılı ve takip süresi ile T2DM riski arasında anlamlı bir ilişki bulunamamıştır.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Abstract Objective To estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestational diabetes mellitus (GDM) and healthy controls. Design Systematic review and meta-analysis. Data sources Medline and Embase between January 2000 and December 2019, studies published in English and conducted on humans. Eligibility criteria for selecting studies Observational studies investigating progression to T2DM. Inclusion criteria were postpartum follow-up for at least 12 months, incident physician based diagnosis of diabetes, T2DM reported as a separate outcome rather than combined with impaired fasting glucose or impaired glucose tolerance, and studies with both a group of patients with GDM and a control group. Results This meta-analysis of 20 studies assessed a total of 1 332 373 individuals (67 956 women with GDM and 1 264 417 controls). Data were pooled by random effects meta-analysis models, and heterogeneity was assessed by use of the I 2 statistic. The pooled relative risk for the incidence of T2DM between participants with GDM and controls was estimated. Reasons for heterogeneity between studies were investigated by prespecified subgroup and meta-regression analyses. Publication bias was assessed by funnel plots and, overall, studies were deemed to have a low risk of bias (P=0.58 and P=0.90). The overall relative risk for T2DM was almost 10 times higher in women with previous GDM than in healthy controls (9.51, 95% confidence interval 7.14 to 12.67, P<0.001). In populations of women with previous GDM, the cumulative incidence of T2DM was 16.46% (95% confidence interval 16.16% to 16.77%) in women of mixed ethnicity, 15.58% (13.30% to 17.86%) in a predominantly non-white population, and 9.91% (9.39% to 10.42%) in a white population. These differences were not statistically significant between subgroups (white v mixed populations, P=0.26; white v non-white populations, P=0.54). Meta-regression analyses showed that the study effect size was not significantly associated with mean study age, body mass index, publication year, and length of follow-up. Conclusions Women with a history of GDM appear to have a nearly 10-fold higher risk of developing T2DM than those with a normoglycaemic pregnancy. The magnitude of this risk highlights the importance of intervening to prevent the onset of T2DM, particularly in the early years after pregnancy. Systematic review registration PROSPERO CRD42019123079.
Yazarların özeti; kaynağından alınmıştır. BMJ, 2020 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Kadın Hastalıkları ve Doğum
Obstetrics and GynecologyMedicine